Sorted By:

Relevance


Supporting Better Patient Outcomes Through Reform

PhRMA  |  Blog Post

Five ‘building blocks’ could help ensure that the HHS’ initiative achieves better outcomes for all patients, including: incorporating clear mechanisms for recognizing new treatment advances, including personalized medicines; expanding the foundation of quality and patient-reported outcomes measures in alternative payment models; promoting informed patient decision-making from the range of available tests and treatment options; taking a holistic, system-wide view of cost and quality; and creating mechanisms for broader stakeholder input in development and evaluation of new payment models.
http://catalyst.phrma.org/supporting-better-patient-outcomes-through-reform

PhRMA Statement on the ITC Report on India

PhRMA  |  Press Release

International Trade Commission’s second report in September 2015.
https://www.phrma.org/press-release/phrma-statement-on-the-itc-report-on-india

PhRMA Statement on PCAST Innovation Report

PhRMA  |  Press Release

“This report couldn’t have come at a better time andwe look forward to having discussions with members of the new Congress and the Administration on steps we can take to help ensure the U.S. remains the world leader in medical innovation.”
https://www.phrma.org/press-release/phrma-statement-on-pcast-innovation-report

R&D Investment by U.S. Biopharmaceutical Companies Reached Record Levels in 2010

PhRMA  |  Press Release

Industry-wide research and investment reached a record $67.4 billion in 2010.
https://www.phrma.org/press-release/randd-investment-by-u-s-biopharmaceutical-companies-reached-record-levels-in-2010

The Innovative Pharmaceutical Manufacturing Industry

PhRMA  |  Report

This companion report was developed with support by PhRMA to explore the economic contributions of manufacturing performed by the innovative biopharmaceutical industry versus other IP-intensive industries across a number of key measures.
https://www.phrma.org/report/the-innovative-pharmaceutical-manufacturing-industry

New report highlights need to speed patent examination

PhRMA  |  Blog Post

The report found that while every country faces its own unique problems related to the backlog of patent applications, new trends and leaders in patent innovation have emerged.
http://catalyst.phrma.org/new-report-highlights-need-to-speed-patent-examination

Canada’s chance to reform its approach to innovation

PhRMA  |  Blog Post

With a recently elected government, Canada has an opportunity to reform its approach to IP and establish a system that encourages innovation and improves access to treatments and cures for Canadians.
http://catalyst.phrma.org/canadas-chance-to-reform-its-approach-to-innovation

ICYMI: A Broad Coalition of Stakeholders Continue to Raise Concerns about Patent Litigation Reform

PhRMA  |  Blog Post

Get alerts on patent litigation reform legislation here.
http://catalyst.phrma.org/icymi-a-broad-coalition-of-stakeholders-continue-to-raise-concerns-about-patent-litigation-reform

New report celebrates a decade of progress in chronic diseases

PhRMA  |  Blog Post

Read the report here: http://phrma.org/decade-of-innovation
http://catalyst.phrma.org/new-report-celebrates-a-decade-of-progress-in-chronic-diseases

R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/randd-spending-by-u-s-biopharmaceutical-companies-reaches-record-levels-in-2008-despite-economic-challenges

PhRMA Statement on Annual Health Care Spending Report

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.3 billion in 2009.
https://www.phrma.org/press-release/phrma-statement-on-annual-health-care-spending-report

RxOpen Activated to Report on Status of Pharmacies in Oklahoma

PhRMA  |  Press Release

With forecasts still calling for dangerous weather across this region of the country, Rx Response will continue to carefully monitor the impact of severe weather on the bio-pharmaceutical supply chain and report the status of area pharmacies at RxOpen.org.
https://www.phrma.org/press-release/rxopen-activated-to-report-on-status-of-pharmacies-in-oklahoma

New PhRMA Report: Medicines in development offer hope for osteoporosis patients and families

PhRMA  |  Blog Post

  View the full report here: http://phrma.org/sites/default/files/pdf/medicines-in-development-report-osteoporosis.pdf
http://catalyst.phrma.org/new-phrma-report-medicines-in-development-offer-hope-for-osteoporosis-patients-and-families

PhRMA Applauds Innovation, Access Policies in US-Japan Report

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-applauds-innovation-access-policies-in-us-japan-report

New Report Reveals Growth Trajectories and Top Policy Factors Affecting Biopharmaceutical Innovation & Growth

PhRMA  |  Press Release

More information about the report can be found here.
https://www.phrma.org/press-release/new-report-reveals-growth-trajectories-and-top-policy-factors-affecting-biopharmaceutical-innovation-and-growth

New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/new-report-shows-97-medicines-and-vaccines-currently-in-development-for-hiv/aids

Biopharmaceutical Company Communications with Health Care Stakeholders

PhRMA  |  Report

Download the report to learn more.
https://www.phrma.org/report/biopharmaceutical-company-communications-with-health-care-stakeholders

New Report: Part B proposal is more aggressive than previous efforts

PhRMA  |  Blog Post

Last week, a new report released by Avalere Health took a closer look at the evolution of CMMI since its creation.
http://catalyst.phrma.org/new-report-part-b-proposal-is-more-aggressive-than-previous-efforts

New Report: Transforming Rare Disease Patients' Lives Through Innovation

PhRMA  |  Press Release

For more information on rare diseases, view the “Medicines in Development for Rare Diseases” report.   
https://www.phrma.org/press-release/new-report-transforming-rare-disease-patients-lives-through-innovation

Comprehensive Health Care Reform Should Be National Priority

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/comprehensive-health-care-reform-should-be-national-priority

340B

PhRMA  |  From PhRMA

Areas of needed reform include: Patient Definition: The definition of “patient” for purposes of the 340B program should ensure the program’s benefits flow to the individuals whom Congress sought to help, primarily vulnerable or uninsured patients.
https://www.phrma.org/advocacy/340b

PhRMA Statement on House Health Care Reform Bill

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-statement-on-house-health-care-reform-bill

21st Century Cures: An Update on the President’s PCAST Report

PhRMA  |  Speeches & Communication

The Pharmaceutical Research and Manufacturers of America (PhRMA) believes that the challenges affecting the ability to provide life-saving and life-enhancing new medicines to patients in an efficient and timely manner are significant, and addressing them will require the involvement of and partne...
https://www.phrma.org/public-communication/21st-century-cures-a-update-on-the-president-s-pcast-report

PhRMA Statement on the United Nations High Level Panel Report on Access to Medicines

PhRMA  |  Press Release

As such, neither this report nor its recommendations can be a sound basis for further consideration or action by the UN system.”
https://www.phrma.org/press-release/phrma-statement-on-the-united-nations-high-level-panel-report-on-access-to-medicines

Report Outlines Many New Medicines in Development to Battle Diabetes Epidemic Affecting More than 30 Million Americans

PhRMA  |  Press Release

The full “Medicines in Development for Diabetes” report can be downloaded here. 
https://www.phrma.org/press-release/report-outlines-many-new-medicines-in-development-to-battle-diabetes-epidemic-affecting-more-than-30-million-americans

You have reviewed the first 175 results out of 1029. Each page contains 25 results. You're on page 7.

prev 7 8 9 10 11 12 next